Tag: blueleaf
Deep venous valve technologies set to address “large unmet need worldwide”
The pursuit of a cure for deep venous valvular reflux—long considered to be the “holy grail” of deep venous disease—is underway, with new technologies...
Venous valve technologies set to address “large unmet need worldwide”
“I see a future where this technology may be used to treat people early and avoid the devastating long term consequences of venous insufficiency”...
InterVene’s BlueLeaf endovenous valve formation system granted FDA Breakthrough Device designation
InterVene recently announced that it has received Breakthrough Device designation from the US Food and Drug Administration (FDA) for the company’s BlueLeaf endovenous valve...
“The future is very bright for venous valve replacement”
The progress of two “promising” new devices in the venous valve replacement space were outlined during a special session at the Society for Vascular...
InterVene Raises $15 Million in Series B funding for catheter-based deep...
InterVene has announced it has raised US$15 million in a Series B financing round. The company’s BlueLeaf Endovenous Valve Formation System is the first catheter-based solution...